• 1st annual meeting of the U-THI-Clust

    IDIBAPS’ Esther Koplowitz Centre Barcelona, Spain
    Cluster

    The first annual meeting of the EU Cancer Mission‘s Understanding (tumour-host interactions) Cluster held in January 2025 brought together leading cancer researchers, policymakers, and patient representatives at IDIBAPS’ Esther Koplowitz Centre in Barcelona. The event, organised by the THRIVE project, aimed to strengthen collaboration and shape policies to advance Europe’s fight against cancer, in line […]

  • GLIOMATCH 3rd Consortium Meeting

    UDUS Düsseldorf, Germany
    Internal

    From 25 to 27 March 2025, the GLIOMATCH consortium convened in Düsseldorf, Germany, for its third consortium meeting. The meeting was held in-person and hosted by the partner University of Düsseldorf (UDUS). Over 40 experts from across Europe gathered to assess progress of the past year and plan the next phase of the GLIOMATCH project.

  • GLIOMATCH 4th Consortium Meeting (online)

    Internal

    The 4th GLIOMATCH consortium meeting is held online on 17 November 2025 and focuses on scientific discussions and stakeholder involvement, including the distribution of the GLIOMATCH patient survey.

  • SNO Society for Neuro-Oncology Annual Meeting 2025

    SNO 2025 Honolulu, Hawaii, United States
    Conference

    Make your plans to attend the 7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, held in conjunction with the 30th Society for Neuro-Oncology Annual Meeting & Education Day in beautiful Honolulu, Hawaii! This year’s meeting is particularly special, as we celebrate SNO’s 30th anniversary—a milestone that underscores three decades of progress, collaboration, and […]

  • 7th Glioblastoma Drug Development Summit 2026

    GBM drug development summit 2026 Boston, MA, United States
    Conference

    Innovating Novel Combination Therapies & Maximising Preclinical & Clinical Development to Improve Glioblastoma Targeting & Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need The glioblastoma drug development space has been energized by Merck’s acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged […]

  • 2nd annual meeting of the U-THI-Clust

    Nencki Institute Warsaw, Poland
    Cluster

    The 2nd annual meeting of the U-THI-Clust is held in Warsaw, Poland and hosted by HIT-GLIO at the Nencki Institute.

  • AACR American Association for Cancer Research Annual Meeting 2026

    San Diego Convention Center San Diego, California, United States
    Conference

    The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting […]